Batch Pharmacy/Compliance Score: 3.8/5.0
Scheduled Batch & Periodic Processing | Internal audience
The Drug Supply Chain Security Act (DSCSA) mandates end-to-end tracking of pharmaceuticals from manufacturer to pharmacy, with serialization (unique product identifiers) required for all drugs. Compliance requires meticulous matching of product lot numbers, NDC codes, and quantities across manufacturer shipments, wholesale distributor receipt logs, and pharmacy purchase orders. Controlled substance tracking adds DEA reporting requirements. Non-compliance results in federal penalties and potential loss of pharmacy licenses. Manual verification across multiple systems (pharmacy inventory, distributor portals, DEA databases) is error-prone and time-consuming.
| Aspect | Details |
|---|---|
| Data Sources | Manufacturer product serialization records (shipped lot numbers, NDC codes, quantities), wholesale distributor receipt/shipment logs (TraceLink, McKesson, Cardinal Health systems), pharmacy inventory management system, DEA CSOS (Controlled Substance Ordering System) records, state PDMP databases, pharmacy purchase orders and receiving logs. |
| Data Classification | Confidential business data (supplier contracts, inventory), DEA regulated data (controlled substance records) |
| Data Quality Needs | High , lot numbers must be exact; dates must align; system synchronization critical. |
| Complexity | High , integration with multiple external systems; controlled substance reconciliation; exception handling. |
| Criterion | Weight | Score (1-5) | Weighted |
|---|---|---|---|
| Time Recaptured | 15% | 4 | 0.60 |
| Error Reduction | 10% | 4 | 0.40 |
| Cost Avoidance | 10% | 4 | 0.40 |
| Strategic Leverage | 5% | 4 | 0.20 |
| Data Availability | 15% | 4 | 0.60 |
| Process Clarity | 15% | 4 | 0.60 |
| Ease of Implementation | 10% | 4 | 0.40 |
| Fallback Available | 10% | 4 | 0.40 |
| Audience (Int/Ext) | 10% | 4 | 0.40 |
| Composite | 100% | 3.80 |
Moderate Fit. Integration with multiple external systems (TraceLink, PDMP, ERP) is complex. Controlled substance reconciliation logic is intricate. Initial build: 8 weeks for core serialization validation + system integrations. Requires significant pharmacy operations input. Deployment via compliance dashboard + automated quarterly reporting. Ongoing maintenance: 2 weeks per quarter for new regulatory rule updates.
From zero to a governed, production agent in 6 weeks.
Sprint Factory Schedule a Briefing